Article Information
History
- April 22, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jason M Samuels, MD1,*,
- Kevin Niswender, MD2,
- Christianne L. Roumie, MD MPH2,3,
- Wesley Self, MD MPH4,5,
- Michael Holzman, MD MPH1,
- Matthew Spann, MD MMHC1,
- C. Robb Flynn, PhD1,
- Fei Ye, PhD MSPH6,
- Rebecca Irlmeier, MS6,
- Luke M. Funk, MD, MPH7,8 and
- Mayur Patel, MD MPH9,10
- 1Division of General Surgery, Vanderbilt University Medical Center, Section of Surgical Sciences, Nashville, TN
- 2Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
- 3Tennessee Valley VA Health Care System Geriatric Research Education Clinical Center (GRECC), Nashville, TN
- 4Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tennessee
- 5Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
- 6Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee
- 7Department of Surgery, University of Wisconsin-Madison, Madison, WI
- 8Department of Surgery, William S. Middleton Veterans Health Administration Hospital, Madison, WI
- 9Division Chief of Acute Care Surgery, CIBS Center Investigator & Executive Committee Member, Vice-Chair of Professional Development, Vanderbilt University, Nashville, TN
- 10Department of Surgery, Ingram Chair in Surgical Sciences, Veteran Administration Tennessee
- ↵* Corresponding author; email: jason.m.samuels{at}vumc.org
Posted April 22, 2024.
Adverse Event Comparison between Glucagon-like Peptide-1 Receptor Agonists and Other Anti-Obesity Medications Following Bariatric Surgery
